Ustekinumab (Stelara) therapy for Crohn's disease
https://libcat.nshealth.ca/en/permalink/chpams35722
Nova Scotia Health Authority. QEII. Gastroenterology.
Halifax, NS:
Nova Scotia Health Authority
, 2017.
- Pamphlet Number
- 1695
- Available Online
- View Pamphlet
Your healthcare provider believes treatment with a medicine called ustekinumab (Stelara®) may help to manage your Crohn’s disease. In this pamphlet you will find basic information about ustekinumab to help you make an informed decision about whether or not to use this treatment. Topics include: a brief description of the medicine, how it works, how it is given, precautions, side effects, symptoms to watch out for, pregnancy & breastfeeding, and other important things to know when undergoing thi…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Gastroenterology
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2017
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (9 p.) : digital, PDF file
- Subjects (MeSH)
- Ustekinumab
- Crohn Disease - drug therapy
- Subjects (LCSH)
- Crohn's disease
- Gastrointestinal agents
- Abstract
- Your healthcare provider believes treatment with a medicine called ustekinumab (Stelara®) may help to manage your Crohn’s disease. In this pamphlet you will find basic information about ustekinumab to help you make an informed decision about whether or not to use this treatment. Topics include: a brief description of the medicine, how it works, how it is given, precautions, side effects, symptoms to watch out for, pregnancy & breastfeeding, and other important things to know when undergoing this treatment.
- Responsibility
- Prepared by: Alison Harding BSc, Jennifer Stewart RN, CCRP, Dr. Des Leddin; Gastroenterology
- Pamphlet Number
- 1695
